DNA hypomethylation promotes UHRF1-and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states
- Mol Cell. 2024 Nov 25:S1097-2765(24)00914-6. doi: 10.1016/j.molcel.2024.11.009.
- 1. Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, USA.
- 2. Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- 3. Cell Signaling Technology, Danvers, MA 01923, USA.
- 4. Department of Structural Biology, Van Andel Institute, Grand Rapids, MI 49503, USA.
- 5. Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, USA. Electronic address: [email protected].
Mono-ubiquitination of lysine 18 on histone H3 (H3K18ub), catalyzed by UHRF1, is a DNMT1 docking site that facilitates replication-coupled DNA methylation maintenance. Its functions beyond this are unknown. Here, we genomically map simultaneous increases in UHRF1-dependent H3K18ub and SUV39H1/H2-dependent H3K9me3 following DNMT1 inhibition. Mechanistically, transient accumulation of hemi-methylated DNA at CpG islands facilitates UHRF1 recruitment and E3 Ligase activity toward H3K18. Notably, H3K18ub enhances SUV39H1/H2 methyltransferase activity and, in colon Cancer cells, nucleates new H3K9me3 domains at CpG island promoters of DNA methylation-silenced tumor suppressor genes (TSGs). Disrupting UHRF1 enzyme activity prevents H3K9me3 accumulation while promoting PRC2-dependent H3K27me3 as a tertiary layer of gene repression in these regions. By contrast, disrupting H3K18ub-dependent SUV39H1/H2 activity enhances the transcriptional activating and antiproliferative effects of DNMT1 inhibition. Collectively, these findings reveal roles for UHRF1 and H3K18ub in regulating a hierarchy of repressive histone methylation signaling and rationalize a combination strategy for epigenetic Cancer therapy.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Histone MethyltransferaseResearch Areas: Cancer